Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

4.48
Delayed Data
As of 3:59pm ET
 -0.08 / -1.75%
Today’s Change
4.33
Today|||52-Week Range
8.38
-23.55%
Year-to-Date
No recent news for Keryx Biopharmaceuticals Inc.

Today’s Trading

Previous close4.56
Today’s open4.57
Day’s range4.38 - 4.59
Volume1,560,681
Average volume (3 months)1,644,566
Market cap$541.5M
Data as of 3:59pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)-27.73%
Earnings growth (this year)+11.27%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+133.79%
P/E ratioNM
Price/Sales19.39
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ENTAEnanta Pharmaceutica...+0.01+0.02%
TGTXTG Therapeutics Inc-0.20-2.42%
PTCTPTC Therapeutics Inc-0.31-1.91%
ADROAduro Biotech Inc+0.40+5.10%
Data as of 4:00pm ET, 12/12/2017

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$32.0M
Annual profit (last year)-$161.1M
Net profit margin-503.69%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Operating Officer &
Senior Vice President
Christine A. Carberry
Corporate headquarters
Boston, Massachusetts

Forecasts